Un essai contrôlé randomisé de la sertraline chez de jeunes enfants atteints de trouble du spectre de l’autisme

Titre original en anglais : A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder

Potter, L. A., Scholze, D. A., Biag, H. M. B., Schneider, A., Chen, Y., Nguyen, D. V., Rajaratnam, A., Rivera, S. M., Dwyer, P., Tassone, F., Olaby, R. R. A., Choudhary, N. S., Salcedo‐Arellano, M. J., & Hagerman, R. J. (2019). A Randomized Controlled Trial of Sertraline in Young Children With Autism Spectrum Disorder. Frontiers in Psychiatry, 10, 810-810. https://doi.org/10.3389/fpsyt.2019.00810

Date de publication: 06/11/2019 Ajout dans AutiHub: 05/07/2026 Type: Article Langue de l’article: Anglais

Cette publication est intégrée dans AutiHub via :

Auteurs

Auteur·ices des publications
14
Auteur·ices de la publication identifié·es comme autistes
1 / 14 (7,1 %)

Résumé

Objectif : Il a été montré, dans des études observationnelles et des rapports anecdotiques, que les inhibiteurs sélectifs de la recapture de la sérotonine tels que la sertraline améliorent le développement du langage chez de jeunes enfants atteints du syndrome de l’X fragile (FXS). Un précédent essai contrôlé de la sertraline chez de jeunes enfants atteints de FXS a constaté une amélioration significative du développement du langage expressif, telle que mesurée par les Mullen Scales of Early Learning (MSEL), chez ceux présentant un trouble du spectre de l’autisme (TSA) comorbide lors d’une analyse post hoc, ce qui a incité les auteurs à examiner si la sertraline est également indiquée dans le TSA non syndromique. Méthodes : Les auteurs ont évalué l’efficacité de 6 mois de traitement par sertraline à faible dose dans un essai randomisé, en double aveugle, contrôlé contre placebo, chez 58 enfants atteints de TSA âgés de 24 à 72 mois. Résultats : Cent soixante-dix-neuf sujets ont été évalués quant à leur admissibilité, et 58 ont été randomisés pour recevoir de la sertraline (32) ou un placebo (26). Huit sujets du groupe sertraline et cinq du groupe placebo ont arrêté l’étude. L’analyse en intention de traiter n’a montré aucune différence significative par rapport au placebo concernant les critères de jugement principaux (score brut de langage expressif MSEL et score combiné d’équivalent d’âge) ni les critères de jugement secondaires. La sertraline a été bien tolérée, sans différence d’effets indésirables entre les groupes sertraline et placebo. Aucun événement indésirable grave possiblement lié au traitement de l’étude ne s’est produit. Conclusion : Cet essai contrôlé randomisé du traitement par sertraline n’a montré aucun bénéfice concernant les mesures des critères de jugement principaux ou secondaires. Pendant la période de 6 mois, le traitement chez de jeunes enfants atteints de TSA semble sûr, bien que les effets indésirables à long terme de la sertraline à faible dose durant la petite enfance soient inconnus. Identifiant ClinicalTrials.gov : NCT02385799

Objective: Selective serotonin reuptake inhibitors like sertraline have been shown in observational studies and anecdotal reports to improve language development in young children with fragile X syndrome (FXS). A previous controlled trial of sertraline in young children with FXS found significant improvement in expressive language development as measured by the Mullen Scales of Early Learning (MSEL) among those with comorbid autism spectrum disorder (ASD) in post hoc analysis, prompting the authors to probe whether sertraline is also indicated in nonsyndromic ASD. Methods: The authors evaluated the efficacy of 6 months of treatment with low-dose sertraline in a randomized, double-blind, placebo-controlled trial in 58 children with ASD aged 24 to 72 months. Results: 179 subjects were screened for eligibility, and 58 were randomized to sertraline (32) or placebo (26). Eight subjects from the sertraline arm and five from the placebo arm discontinued. Intent-to-treat analysis showed no significant difference from placebo on the primary outcomes (MSEL expressive language raw score and age equivalent combined score) or secondary outcomes. Sertraline was well tolerated, with no difference in side effects between sertraline and placebo groups. No serious adverse events possibly related to study treatment occurred. Conclusion: This randomized controlled trial of sertraline treatment showed no benefit with respect to primary or secondary outcome measures. For the 6-month period, treatment in young children with ASD appears safe, although the long-term side effects of low-dose sertraline in early childhood are unknown. Clinicaltrials.gov Identifier: NCT02385799

Bibliographie citée par cette référence

Les références citées sont importées depuis des sources externes de métadonnées lorsqu’elles sont disponibles. La liste peut être partielle.

Vue d’ensemble de l’inclusion dans la bibliographie

Ces indicateurs décrivent la bibliographie citée importée pour cette publication. Les métriques de références citées utilisent le total des références citées comme dénominateur. Les métriques d’auteurices cité·es indiquent si elles utilisent toutes les occurrences d’auteurices cité·es ou seulement les occurrences rattachées à des auteurices déjà intégré·es à la base de données AutiHub. Ils utilisent les rattachements mis en cache entre les auteurices cité·es et les auteurices intégré·es à la base de données AutiHub. Dernier calcul : 16/08/2026 11:30.

Références citées
52
Nombre total de références citées intégrées pour cette publication.
Références citées avec un·e auteur·ice identifié·e comme autiste
0 / 52 (0,0 %)
Occurrences d’auteur·ices cité·es identifié·es comme autistes
0 / 669 (0,0 %)
Parmi les occurrences rattachées à des auteurices intégré·es à la base de données AutiHub : 0 / 63 (0,0 %). Auteurices cité·es distinct·es identifié·es comme autistes : 0 / 606 (0,0 %).
Occurrences citées rattachées à la base AutiHub
63 / 669 (9,4 %)
Auteurices cité·es distinct·es rattaché·es : 37 / 606 (6,1 %)
Occurrences rattachées, non identifiées comme autistes
63 / 63 (100,0 %)
Parmi les seules occurrences rattachées. Sur l’ensemble des occurrences d’auteurices cité·es : 63 / 669 (9,4 %). Auteurices cité·es distinct·es rattaché·es, non identifié·es comme autistes : 37 / 37 (100,0 %).
2 entrées de bibliographie citée n’ont pas pu être entièrement enrichies à partir des métadonnées DOI.
Crossref: introuvable (1) · DataCite: introuvable (1)
  1. Sarah M. Reinhard , Khaleel Razak , Iryna M. Ethell (2015). A delicate balance: role of MMP-9 in brain development and pathophysiology of neurodevelopmental disorders . Frontiers in Cellular Neuroscience, 9, 280. Frontiers Media SA.
    Crossref OpenAlex OpenCitations
  2. FragXis Study Group , Eriene A Youssef , Elizabeth Berry‐Kravis , Christian Czech , Randi J. Hagerman , David Hessl et al. (2018). Effect of the mGluR5-NAM Basimglurant on Behavior in Adolescents and Adults with Fragile X Syndrome in a Randomized, Double-Blind, Placebo-Controlled Trial: FragXis Phase 2 Results . Neuropsychopharmacology, 43(3), 503-512. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations
  3. Juan Pablo Lucchelli , Gilles Bertschy (2018). Low-Dose Fluoxetine in Four Children with Autistic Spectrum Disorder Improves Self-Injurious Behavior, ADHD-Like Symptoms, and Irritability . Case Reports in Psychiatry, 2018, 1-4. Wiley.
    Crossref OpenAlex OpenCitations
  4. Katrina Williams , Amanda Brignell , Melinda Randall , Natalie Silove , Philip Hazell (2013). Selective serotonin reuptake inhibitors (SSRIs) for autism spectrum disorders (ASD) . Cochrane Database of Systematic Reviews, 2013(8), Cd004677. Wiley.
    Crossref OpenAlex OpenCitations
  5. The DDD Study , Silvia De Rubeis , Homozygosity Mapping Collaborative for Autism , Xin He , Arthur P. Goldberg , Christopher S. Poultney et al. (2014). Synaptic, transcriptional and chromatin genes disrupted in autism . Nature, 515(7526), 209-215. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations
  6. Flora Tassone , Nimrah S. Choudhary , Nimrah S. Choudhary , Blythe Durbin-Johnson , Robin Hansen , Irva Hertz-Picciotto et al. (2013). Identification of Expanded Alleles of the FMR1 Gene in the CHildhood Autism Risks from Genes and Environment (CHARGE) Study . Journal of Autism and Developmental Disorders, 43(3), 530-539. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations
  7. M. Albert Basson , Richard J. Wingate (2013). Congenital hypoplasia of the cerebellum: developmental causes and behavioral consequences . Frontiers in Neuroanatomy, 7, 29. Frontiers Media SA.
    Crossref OpenAlex OpenCitations
  8. Jon Baio , Lisa Wiggins , Deborah L. Christensen , Matthew J Maenner , Julie Daniels , Zachary Warren et al. (2018). Prevalence of Autism Spectrum Disorder Among Children Aged 8 Years — Autism and Developmental Disabilities Monitoring Network, 11 Sites, United States, 2014 . MMWR. Surveillance Summaries, 67(6), 1-23. Centers for Disease Control MMWR Office.
    Crossref OpenAlex OpenCitations
  9. R.M. Meredith (2015). Sensitive and critical periods during neurotypical and aberrant neurodevelopment: A framework for neurodevelopmental disorders . Neuroscience & Biobehavioral Reviews, 50, 180-188. Elsevier BV.
    Crossref OpenAlex OpenCitations
  10. Ivan Iossifov , Brian J. O’Roak , Stephan J. Sanders , Michael Ronemus , Niklas Krumm , Dan Levy et al. (2014). The contribution of de novo coding mutations to autism spectrum disorder . Nature, 515(7526), 216-221. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations
  11. Amene Saghazadeh , Nima Rezaei (2017). Brain-Derived Neurotrophic Factor Levels in Autism: A Systematic Review and Meta-Analysis . Journal of Autism and Developmental Disorders, 47(4), 1018-1029. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations
  12. Ivan Iossifov , Michael Ronemus , Dan Levy , Zihua Wang , Inessa Hakker , Julie Rosenbaum et al. (2012). De Novo Gene Disruptions in Children on the Autistic Spectrum . Neuron, 74(2), 285-299. Elsevier BV.
    Crossref OpenAlex OpenCitations
  13. M. Hasan , J.-E. Seo , K.A. Rahaman , M.-J. Kang , B.-H. Jung , O.-S. Kwon (2016). Increased levels of brain serotonin correlated with MMP-9 activity and IL-4 levels resulted in severe experimental autoimmune encephalomyelitis (EAE) in obese mice . Neuroscience, 319, 168-182. Elsevier BV.
    Crossref OpenAlex OpenCitations
  14. Katja Beesdo , Susanne Knappe , Daniel S. Pine (2009). Anxiety and Anxiety Disorders in Children and Adolescents: Developmental Issues and Implications for DSM-V . Psychiatric Clinics of North America, 32(3), 483-524. Elsevier BV.
    Crossref OpenAlex OpenCitations
  15. Shun Qiang Lo , Judy C. G. Sng , George J. Augustine (2017). Defining a critical period for inhibitory circuits within the somatosensory cortex . Scientific Reports, 7(1), 7271. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations
  16. Judith S. Miller , D.N. McIntosh , J. McGrath , V. Shyu , M. Lampe , A.K. Taylor et al. (1999). Electrodermal responses to sensory stimuli in individuals with fragile X syndrome: A preliminary report . Am J Med Genet, 83(4), 268-279.
    Type: Article DOI: 10.1002/(sici)1096-8628(19990402)83:4 OpenAlex: https://openalex.org/W2107291133 Crossref: introuvable DataCite: introuvable
    Crossref OpenAlex OpenCitations
  17. Giovanni Abrahao Salum , Diogo Araujo DeSousa , Maria Conceicao do Rosario , Daniel Samuel Pine , Gisele Gus Manfro (2013). Pediatric anxiety disorders: from neuroscience to evidence-based clinical practice . Revista Brasileira de Psiquiatria, 35(suppl 1), S03-S21. EDITORA SCIENTIFIC.
    Crossref OpenAlex OpenCitations
  18. Qionger He , Erica D. Arroyo , Samuel N. Smukowski , Jian Xu , Claire Piochon , Jeffrey N. Savas et al. (2019). Critical period inhibition of NKCC1 rectifies synapse plasticity in the somatosensory cortex and restores adult tactile response maps in fragile X mice . Molecular Psychiatry, 24(11), 1732-1747. Springer Science and Business Media LLC.
    OpenAlex OpenCitations
  19. Tao Su , Hong-Xing Fan , Tao Jiang , Wei-Wen Sun , Wei-Yi Den , Mei-Mei Gao et al. (2011). Early continuous inhibition of group 1 mGlu signaling partially rescues dendritic spine abnormalities in the Fmr1 knockout mouse model for fragile X syndrome . Psychopharmacology, 215(2), 291-300. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations
  20. Géraldine Dawson , Sally J. Rogers , Jeffrey Munson , Milani Smith , Jamie Winter , Jessica Greenson et al. (2010). Randomized, Controlled Trial of an Intervention for Toddlers With Autism: The Early Start Denver Model . Pediatrics, 125(1), e17-e23. American Academy of Pediatrics (AAP).
    Crossref OpenAlex OpenCitations
  21. Tri Indah Winarni , Andrea Schneider , Mariya Borodyanskara , Randi J. Hagerman (2012). Early Intervention Combined with Targeted Treatment Promotes Cognitive and Behavioral Improvements in Young Children with Fragile X Syndrome . Case Reports in Genetics, 2012, 1-4. Wiley.
    Crossref OpenAlex OpenCitations
  22. Fatima Yousif Ismail , Ali Fatemi , Michael V. Johnston (2017). Cerebral plasticity: Windows of opportunity in the developing brain . European Journal of Paediatric Neurology, 21(1), 23-48. Elsevier BV.
    Crossref OpenAlex OpenCitations
  23. Julie C. Lauterborn , Christopher S. Rex , Eniko Kramár , Lulu Y. Chen , Vijay Pandyarajan , Gary Lynch et al. (2007). Brain-Derived Neurotrophic Factor Rescues Synaptic Plasticity in a Mouse Model of Fragile X Syndrome . The Journal of Neuroscience, 27(40), 10685-10694. Society for Neuroscience.
    Crossref OpenAlex OpenCitations
  24. Laura Greiss Hess , Sarah E. Fitzpatrick , Danh V. Nguyen , Yanjun Chen , Kimberly N. Gaul , Andrea Schneider et al. (2016). A Randomized, Double-Blind, Placebo-Controlled Trial of Low-Dose Sertraline in Young Children With Fragile X Syndrome . Journal of Developmental & Behavioral Pediatrics, 37(8), 619-628. Ovid Technologies (Wolters Kluwer Health).
    Crossref OpenAlex OpenCitations
  25. Michael E. Greenberg , Baoji Xu , Bai Lu , Barbara L. Hempstead (2009). New Insights in the Biology of BDNF Synthesis and Release: Implications in CNS Function . The Journal of Neuroscience, 29(41), 12764-12767. Society for Neuroscience.
    Crossref OpenAlex OpenCitations
  26. Jocelyn J. LeBlanc , Michela Fagiolini (2011). Autism: A “Critical Period” Disorder? Neural Plasticity, 2011, 1-17. Wiley.
    Crossref OpenAlex OpenCitations
  27. Reem Rafik AlOlaby , Stefan R. Sweha , Marisol Silva , Blythe Durbin-Johnson , Carolyn M. Yrigollen , Dalyir Pretto et al. (2017). Molecular biomarkers predictive of sertraline treatment response in young children with fragile X syndrome . Brain and Development, 39(6), 483-492. Elsevier BV.
    Crossref OpenAlex OpenCitations
  28. Fan Mei , Guhan Nagappan , Yang Ke , Todd C. Sacktor , Bai Lu (2011). BDNF Facilitates L-LTP Maintenance in the Absence of Protein Synthesis through PKMζ . PLoS ONE, 6(6), e21568. Public Library of Science (PLoS).
    Crossref OpenAlex OpenCitations
  29. He (2018). Mol Psychiatry . Mol Psychiatry.
    Type: Autre
    Crossref
  30. Sreenivasa R. Chandana , Michael E. Behen , Csaba Juhász , Otto Muzik , Robert D. Rothermel , Thomas J. Mangner et al. (2005). Significance of abnormalities in developmental trajectory and asymmetry of cortical serotonin synthesis in autism . International Journal of Developmental Neuroscience, 23(2-3), 171-182. Wiley.
    Crossref OpenAlex OpenCitations
  31. Lisa Cordeiro , Elizabeth Ballinger , Randi J. Hagerman , David Hessl (2011). Clinical assessment of DSM-IV anxiety disorders in fragile X syndrome: prevalence and characterization . Journal of Neurodevelopmental Disorders, 3(1), 57-67. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations
  32. Géraldine Dawson , Emily J.H. Jones , Kristen Merkle , Kaitlin Venema , Rachel Lowy , Susan Faja et al. (2012). Early Behavioral Intervention Is Associated With Normalized Brain Activity in Young Children With Autism . Journal of the American Academy of Child & Adolescent Psychiatry, 51(11), 1150-1159. Elsevier BV.
    Crossref OpenAlex OpenCitations
  33. L.C. Jansson , L. Louhivuori , H.-K. Wigren , T. Nordström , V. Louhivuori , M.L. Castrén et al. (2012). Brain-derived neurotrophic factor increases the motility of a particular N-methyl-d-aspartate /GABA-responsive subset of neural progenitor cells . Neuroscience, 224, 223-234. Elsevier BV.
    Crossref OpenAlex OpenCitations
  34. P. Bianchi , E. Ciani , S. Guidi , S. Trazzi , D. Felice , G. Grossi et al. (2010). Early Pharmacotherapy Restores Neurogenesis and Cognitive Performance in the Ts65Dn Mouse Model for Down Syndrome . Journal of Neuroscience, 30(26), 8769-8779. Society for Neuroscience.
    Crossref OpenAlex OpenCitations
  35. John M Hoenig , Dennis M Heisey (2001). The Abuse of Power . The American Statistician, 55(1), 19-24. Informa UK Limited.
    Crossref OpenAlex OpenCitations
  36. Luigi Boccuto , Chin-Fu Chen , Ayla R Pittman , Cindy D Skinner , Heather J McCartney , Kelly Jones et al. (2013). Decreased tryptophan metabolism in patients with autism spectrum disorders . Molecular Autism, 4(1), 16. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations
  37. Connor M. Kerns , Philip C. Kendall , Leandra Berry , Margaret C. Souders , Martin E. Franklin , Robert T. Schultz et al. (2014). Traditional and Atypical Presentations of Anxiety in Youth with Autism Spectrum Disorder . Journal of Autism and Developmental Disorders, 44(11), 2851-2861. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations
  38. Xiao-Yan Qin , Yong Cheng (2017). Brain-Derived Neurotrophic Factor in Autism Spectrum Disorder—Reply . JAMA Pediatrics, 171(5), 493. American Medical Association (AMA).
    Crossref OpenAlex OpenCitations
  39. Morsi W Abdallah , Tanja M Michel (2013). Matrix metalloproteinases in autism spectrum disorders . Journal of Molecular Psychiatry, 1(1), 16. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations
  40. Kara Gross Margolis , Zhishan Li , Korey Stevanovic , Virginia Saurman , Narek Israelyan , George M. Anderson et al. (2016). Serotonin transporter variant drives preventable gastrointestinal abnormalities in development and function . Journal of Clinical Investigation, 126(6), 2221-2235. American Society for Clinical Investigation.
    Type: Article DOI: 10.1172/jci84877 OpenAlex: https://openalex.org/W2343547480
    Crossref OpenAlex OpenCitations
  41. Mark N. Ziats , Robin P. Goin-Kochel , Leandra N. Berry , May Ali , Jun Ge , Danielle Guffey et al. (2016). The complex behavioral phenotype of 15q13.3 microdeletion syndrome . Genetics in Medicine, 18(11), 1111-1118. Elsevier BV.
    Crossref OpenAlex OpenCitations
  42. Susan W. White , Donald Oswald , Thomas H. Ollendick , Lawrence Scahill (2009). Anxiety in children and adolescents with autism spectrum disorders . Clinical Psychology Review, 29(3), 216-229. Elsevier BV.
    Crossref OpenAlex OpenCitations
  43. Jill C. Fodstad , Stephanie A. Kerswill , Alexandra C. Kirsch , Ann Lagges , Jonathan Schmidt (2021). Assessment and Treatment of Noise Hypersensitivity in a Teenager with Autism Spectrum Disorder: A Case Study . Journal of Autism and Developmental Disorders, 51(6), 1811-1822. Springer Science and Business Media LLC.
    OpenCitations
  44. Diane C. Chugani , Harry T. Chugani , Max Wiznitzer , Sumit Parikh , Patricia A. Evans , Robin L. Hansen et al. (2016). Efficacy of Low-Dose Buspirone for Restricted and Repetitive Behavior in Young Children with Autism Spectrum Disorder: A Randomized Trial . The Journal of Pediatrics, 170, 45-53.e4. Elsevier BV.
    Crossref OpenAlex OpenCitations
  45. Susan M. Rivera (2017). Low-Dose Sertraline Improves Receptive Language in Children with Fragile X Syndrome when Eye Tracking Methodology is used to Measure Treatment Outcome . Journal of Psychology & Clinical Psychiatry, 7(6). MedCrave Group Kft..
    Crossref OpenAlex
  46. Jordan Ezell , Abigail Hogan , Amanda Fairchild , Kimberly Hills , Jessica Klusek , Leonard Abbeduto et al. (2019). Prevalence and Predictors of Anxiety Disorders in Adolescent and Adult Males with Autism Spectrum Disorder and Fragile X Syndrome . Journal of Autism and Developmental Disorders, 49(3), 1131-1141. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations
  47. Tara L. Wenger , Judith S. Miller , Lauren M. DePolo , Ashley de Marchena , Caitlin C. Clements , Beverly S. Emanuel et al. (2016). 22q11.2 duplication syndrome: elevated rate of autism spectrum disorder and need for medical screening . Molecular Autism, 7(1), 27. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations
  48. Dink (2015). eyetrackingR: An R Library for Eye-Tracking Data Analysis . eyetrackingR: An R Library for Eye-Tracking Data Analysis.
    Type: Autre
    Crossref
  49. Devon M. Coleman , James B. Adams , Amy L. Anderson , Richard E. Frye (2019). Rating of the Effectiveness of 26 Psychiatric and Seizure Medications for Autism Spectrum Disorder: Results of a National Survey . Journal of Child and Adolescent Psychopharmacology, 29(2), 107-123. SAGE Publications.
    Crossref OpenAlex OpenCitations
  50. S. Baer , A. Afenjar , T. Smol , A. Piton , B. Gérard , Y. Alembik et al. (2018). Wiedemann‐Steiner syndrome as a major cause of syndromic intellectual disability: A study of 33 French cases . Clinical Genetics, 94(1), 141-152. Wiley.
    Crossref OpenAlex OpenCitations
  51. Jane E. Roberts , Jordan E. Ezell , Amanda J. Fairchild , Jessica Klusek , Angela J. Thurman , Andrea McDuffie et al. (2018). Biobehavioral composite of social aspects of anxiety in young adults with fragile X syndrome contrasted to autism spectrum disorder . American Journal of Medical Genetics Part B: Neuropsychiatric Genetics, 177(7), 665-675. Wiley.
    Crossref OpenAlex OpenCitations
  52. Leonard Abbeduto , Angela John Thurman , Andrea McDuffie , Jessica Klusek , Robyn Tempero Feigles , W. Ted Brown et al. (2019). ASD Comorbidity in Fragile X Syndrome: Symptom Profile and Predictors of Symptom Severity in Adolescent and Young Adult Males . Journal of Autism and Developmental Disorders, 49(3), 960-977. Springer Science and Business Media LLC.
    Crossref OpenAlex OpenCitations